LEXX: Begins Dosing
Lexaria's human study GLP-1-H26-7 has begun dosing on schedule
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Lexaria's human study GLP-1-H26-7 has begun dosing on schedule
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.